Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.04 USD | -3.71% | -11.66% | -52.14% |
May. 08 | Baird Adjusts Price Target on EyePoint Pharmaceuticals to $38 From $46, Keeps Outperform Rating | MT |
May. 08 | Earnings Flash (EYPT) EYEPOINT PHARMACEUTICALS Posts Q1 Revenue $11.7M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-52.14% | 597M | |
+38.51% | 723B | |
+34.28% | 595B | |
-4.27% | 369B | |
+20.08% | 332B | |
+2.88% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
+0.03% | 168B |
- Stock Market
- Equities
- EYPT Stock
- News EyePoint Pharmaceuticals, Inc.
- EyePoint Pharmaceuticals Shares Fall After Diabetes Drug Fails to Meet Primary Endpoint